{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:52:28Z","timestamp":1792021948018,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Changshu Medical Science and Technology Youth Program","award":["cswsq202102"],"award-info":[{"award-number":["cswsq202102"]}]},{"name":"the Youth\u00a0Science\u00a0Funding Project of\u00a0Suzhou","award":["KJXW2020063"],"award-info":[{"award-number":["KJXW2020063"]}]},{"name":"Clinical\u00a0Key\u00a0Subject Construction Project Foundation of Changshu","award":["CSZDXK202001"],"award-info":[{"award-number":["CSZDXK202001"]}]},{"name":"Introduction\u00a0Project\u00a0of\u00a0Clinical\u00a0Medicine\u00a0Expert\u00a0Team\u00a0for Changshu","award":["CSYJTD202001"],"award-info":[{"award-number":["CSYJTD202001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02172-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T08:10:16Z","timestamp":1749111016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chromosomal instability by low-coverage whole-genome sequencing assay predicts prognosis in bladder cancer patients underwent radical cystectomy"],"prefix":"10.1186","volume":"18","author":[{"given":"Qi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, et al. European association of urology guidelines on Non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in Situ). Eur Urol. 2022;81:75\u201394.","journal-title":"Eur Urol"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, Hern\u00e1ndez V, Linares Espin\u00f3s E, Lorch A, Neuzillet Y, et al. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79:82\u2013104.","journal-title":"Eur Urol"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MOU.0b013e32833cf10e","volume":"20","author":"OP Vrooman","year":"2010","unstructured":"Vrooman OP, Witjes JA. Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice. Curr Opin Urol. 2010;20:437\u201342.","journal-title":"Curr Opin Urol"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","volume":"62","author":"V Soukup","year":"2012","unstructured":"Soukup V, Babjuk M, Bellmunt J, Dalbagni G, Giannarini G, Hakenberg OW, Herr H, Lechevallier E, Ribal MJ. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur Urol. 2012;62:290\u2013302.","journal-title":"Eur Urol"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1200\/JCO.2003.05.073","volume":"21","author":"BW van Rhijn","year":"2003","unstructured":"van Rhijn BW, Vis AN, van der Kwast TH, Kirkels WJ, Radvanyi F, Ooms EC, Chopin DK, Boev\u00e9 ER, J\u00f6bsis AC, Zwarthoff EC. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncology: Official J Am Soc Clin Oncol. 2003;21:1912\u201321.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","volume":"24","author":"S Hern\u00e1ndez","year":"2006","unstructured":"Hern\u00e1ndez S, L\u00f3pez-Knowles E, Lloreta J, Kogevinas M, Amor\u00f3s A, Tard\u00f3n A, Carrato A, Serra C, Malats N, Real FX. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncology: Official J Am Soc Clin Oncol. 2006;24:3664\u201371.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1158\/0008-5472.CAN-06-1182","volume":"66","author":"E L\u00f3pez-Knowles","year":"2006","unstructured":"L\u00f3pez-Knowles E, Hern\u00e1ndez S, Malats N, Kogevinas M, Lloreta J, Carrato A, Tard\u00f3n A, Serra C, Real FX. PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res. 2006;66:7401\u20134.","journal-title":"Cancer Res"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0002-9440(10)65318-7","volume":"154","author":"A Hartmann","year":"1999","unstructured":"Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol. 1999;154:721\u20137.","journal-title":"Am J Pathol"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in Cancer and its microenvironment. Cell. 2018;174:1347\u201360.","journal-title":"Cell"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413\u201321.","journal-title":"Nat Biotechnol"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/nm.4405","volume":"23","author":"JY Goh","year":"2017","unstructured":"Goh JY, Feng M, Wang W, Oguz G, Yatim S, Lee PL, Bao Y, Lim TH, Wang P, Tam WL, et al. Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. Nat Med. 2017;23:1319\u201330.","journal-title":"Nat Med"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553:467\u201372.","journal-title":"Nature"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O\u2019Brien T, Larkin J, Horswell S, et al. Tracking Cancer evolution reveals constrained routes to metastases: tracerx renal. Cell. 2018;173:581\u2013e594512.","journal-title":"Cell"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, Chang MT, Schram AM, Jonsson P, Bandlamudi C, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50:1189\u201395.","journal-title":"Nat Genet"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, et al. Genomic and functional approaches to Understanding Cancer aneuploidy. Cancer Cell. 2018;33:676\u2013e689673.","journal-title":"Cancer Cell"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.breast.2020.07.004","volume":"53","author":"H Mo","year":"2020","unstructured":"Mo H, Wang X, Ma F, Qian Z, Sun X, Yi Z, Guan X, Li L, Liu B, Xu B. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer. Breast (Edinburgh Scotland). 2020;53:111\u20138.","journal-title":"Breast (Edinburgh Scotland)"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0022-3859.123156","volume":"59","author":"N Wadhwa","year":"2013","unstructured":"Wadhwa N, Mathew BB, Jatawa SK, Tiwari A. Genetic instability in urinary bladder cancer: an evolving hallmark. J Postgrad Med. 2013;59:284\u20138.","journal-title":"J Postgrad Med"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"e0187975","DOI":"10.1371\/journal.pone.0187975","volume":"12","author":"KJ Lindquist","year":"2017","unstructured":"Lindquist KJ, Sanford T, Friedlander TW, Paris PL, Porten SP. Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors. PLoS ONE. 2017;12:e0187975.","journal-title":"PLoS ONE"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1373\/clinchem.2018.301341","volume":"65","author":"THT Cheng","year":"2019","unstructured":"Cheng THT, Jiang P, Teoh JYC, Heung MMS, Tam JCW, Sun X, Lee WS, Ni M, Chan RCK, Ng CF, et al. Noninvasive detection of bladder Cancer by Shallow-Depth Genome-Wide bisulfite sequencing of urinary Cell-Free DNA for methylation and copy number profiling. Clin Chem. 2019;65:927\u201336.","journal-title":"Clin Chem"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12967-021-03046-3","volume":"19","author":"M Chen","year":"2021","unstructured":"Chen M, Zhong P, Hong M, Tan J, Yu X, Huang H, Ouyang J, Lin X, Chen P. Applying low coverage whole genome sequencing to detect malignant ovarian mass. J Transl Med. 2021;19:369.","journal-title":"J Transl Med"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4251\/wjgo.v14.i3.690","volume":"14","author":"LP Ye","year":"2022","unstructured":"Ye LP, Mao XL, Zhou XB, Wang Y, Xu SW, He SQ, Qian ZL, Zhang XG, Zhai LJ, Peng JB, et al. Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. World J Gastrointest Oncol. 2022;14:690\u2013702.","journal-title":"World J Gastrointest Oncol"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12920-022-01253-5","volume":"15","author":"Y Guan","year":"2022","unstructured":"Guan Y, Wang X, Guan K, Wang D, Bi X, Xiao Z, Xiao Z, Shan X, Hu L, Ma J, et al. Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study. BMC Med Genomics. 2022;15:104.","journal-title":"BMC Med Genomics"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-024-03067-y","volume":"43","author":"X Shi","year":"2024","unstructured":"Shi X, Guo S, Duan Q, Zhang W, Gao S, Jing W, Jiang G, Kong X, Li P, Li Y, et al. Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics. J Exp Clin Cancer Res. 2024;43:145.","journal-title":"J Exp Clin Cancer Res"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1002\/cam4.3142","volume":"9","author":"S Feng","year":"2020","unstructured":"Feng S, Ding Z, Wang J, Qian Z, Li S, Zhang C, Xin H, Liu S, Ding G, Hu M, et al. Investigation of plasma cell-free cancer genome chromosomal instability as a tool for targeted minimally invasive biomarkers for primary liver cancer diagnoses. Cancer Med. 2020;9:5075\u201385.","journal-title":"Cancer Med"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"e19323","DOI":"10.1016\/j.heliyon.2023.e19323","volume":"9","author":"H Qiu","year":"2023","unstructured":"Qiu H, Wang M, Cao T, Feng Y, Zhang Y, Guo R. Low-coverage whole-genome sequencing for the effective diagnosis of early endometrial cancer: A pilot study. Heliyon. 2023;9:e19323.","journal-title":"Heliyon"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.trsl.2023.07.005","volume":"262","author":"L Chen","year":"2023","unstructured":"Chen L, Ma R, Luo C, Xie Q, Ning X, Sun K, Meng F, Zhou M, Sun J. Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA. Transl Res. 2023;262:12\u201324.","journal-title":"Transl Res"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.modpat.2024.100465","volume":"37","author":"B Batai","year":"2024","unstructured":"Batai B, Kiss L, Varga L, Nagy A, Househam J, Baker AM, Laszlo T, Udvari A, Horvath R, Nagy T, et al. Profiling of copy number alterations using Low-Coverage Whole-Genome sequencing informs differential diagnosis and prognosis in primary cutaneous follicle center lymphoma. Mod Pathol. 2024;37:100465.","journal-title":"Mod Pathol"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.3802\/jgo.2018.29.e78","volume":"29","author":"T Ren","year":"2018","unstructured":"Ren T, Suo J, Liu S, Wang S, Shu S, Xiang Y, Lang JH. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer. J Gynecol Oncol. 2018;29:e78.","journal-title":"J Gynecol Oncol"},{"key":"2172_CR29","doi-asserted-by":"publisher","first-page":"22445","DOI":"10.1038\/s41598-023-49811-w","volume":"13","author":"PV Salachan","year":"2023","unstructured":"Salachan PV, Ulhoi BP, Borre M, Sorensen KD. Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters. Sci Rep. 2023;13:22445.","journal-title":"Sci Rep"},{"key":"2172_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.hbpd.2024.03.002","volume":"23","author":"RH Chen","year":"2024","unstructured":"Chen RH, Cao JY, Feng S, Huang HT, Lin YM, Jiang JY, Yi XW, Ling Q. Integrated chromosomal instability and tumor Microbiome redefined prognosis-related subtypes of pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2024;23:620\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2172_CR31","doi-asserted-by":"publisher","first-page":"8359","DOI":"10.1007\/s00432-023-04716-z","volume":"149","author":"JJ Qin","year":"2023","unstructured":"Qin JJ, Xue F, Shen ZL, Chen XZ. Low-coverage and cost-effective whole-genome sequencing assay for glioma risk stratification. J Cancer Res Clin Oncol. 2023;149:8359\u201367.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2172_CR32","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2147\/CMAR.S295675","volume":"13","author":"YX Cai","year":"2021","unstructured":"Cai YX, Yang X, Lin S, Xu YW, Zhu SW, Fan DM, Zhao M, Zhang YB, Yang XX, Li X. Low-Coverage sequencing of urine sediment DNA for detection of copy number aberrations in bladder Cancer. Cancer Manag Res. 2021;13:1943\u201353.","journal-title":"Cancer Manag Res"},{"key":"2172_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, B\u00f8rresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"2172_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138.","journal-title":"Nature"},{"key":"2172_CR35","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.1073\/pnas.1310522110","volume":"110","author":"PS Rachakonda","year":"2013","unstructured":"Rachakonda PS, Hosen I, de Verdier PJ, Fallah M, Heidenreich B, Ryk C, Wiklund NP, Steineck G, Schadendorf D, Hemminki K, et al. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc Natl Acad Sci USA. 2013;110:17426\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2172_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","volume":"65","author":"Y Allory","year":"2014","unstructured":"Allory Y, Beukers W, Sagrera A, Fl\u00e1ndez M, Marqu\u00e9s M, M\u00e1rquez M, van der Keur KA, Dyrskjot L, Lurkin I, Vermeij M, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol. 2014;65:360\u20136.","journal-title":"Eur Urol"},{"key":"2172_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.anndiagpath.2015.12.002","volume":"21","author":"B Kurtis","year":"2016","unstructured":"Kurtis B, Zhuge J, Ojaimi C, Ye F, Cai D, Zhang D, Fallon JT, Zhong M. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Annals Diagn Pathol. 2016;21:7\u201311.","journal-title":"Annals Diagn Pathol"},{"key":"2172_CR38","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/ijc.31935","volume":"144","author":"R Le\u00e3o","year":"2019","unstructured":"Le\u00e3o R, Lee D, Figueiredo A, Hermanns T, Wild P, Komosa M, Lau I, Mistry M, Nunes NM, Price AJ, et al. Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer. Int J Cancer. 2019;144:1676\u201384.","journal-title":"Int J Cancer"},{"key":"2172_CR39","first-page":"1006","volume-title":"Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer","author":"S Borah","year":"2015","unstructured":"Borah S, Xi L, Zaug AJ, Powell NM, Dancik GM, Cohen SB, Costello JC, Theodorescu D, Cech TR. Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Volume 347. New York, NY): Science; 2015. pp. 1006\u201310."},{"key":"2172_CR40","doi-asserted-by":"crossref","unstructured":"Zhu S, Ma AH, Zhu Z, Adib E, Rao T, Li N, Ni K, Chittepu V, Prabhala R, Garisto Risco J et al. Synergistic antitumor activity of pan-PI3K Inhibition and immune checkpoint Blockade in bladder cancer. J Immunother Cancer 2021, 9.","DOI":"10.1136\/jitc-2021-002917"},{"key":"2172_CR41","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, et al. Next-generation sequencing of nonmuscle invasive bladder Cancer reveals potential biomarkers and rational therapeutic targets. Eur Urol. 2017;72:952\u20139.","journal-title":"Eur Urol"},{"key":"2172_CR42","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1016\/j.cub.2010.01.034","volume":"20","author":"SL Thompson","year":"2010","unstructured":"Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20:R285\u2013295.","journal-title":"Curr Biol"},{"key":"2172_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21:104\u201321.","journal-title":"Nat Rev Cancer"},{"key":"2172_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10120-015-0467-2","volume":"19","author":"X Wang","year":"2016","unstructured":"Wang X, Liu Y, Shao D, Qian Z, Dong Z, Sun Y, Xing X, Cheng X, Du H, Hu Y, et al. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer: Official J Int Gastric Cancer Association Japanese Gastric Cancer Association. 2016;19:116\u201327.","journal-title":"Gastric Cancer: Official J Int Gastric Cancer Association Japanese Gastric Cancer Association"},{"key":"2172_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1083\/jcb.200712029","volume":"180","author":"SL Thompson","year":"2008","unstructured":"Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol. 2008;180:665\u201372.","journal-title":"J Cell Biol"},{"issue":"Suppl 1","key":"2172_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/jcs.025742","volume":"121","author":"T Boveri","year":"2008","unstructured":"Boveri T. Concerning the origin of malignant tumours by Theodor boveri. Translated and annotated by Henry Harris. J Cell Sci. 2008;121(Suppl 1):1\u201384.","journal-title":"J Cell Sci"},{"key":"2172_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1054\/bjoc.2001.1892","volume":"85","author":"D Choma","year":"2001","unstructured":"Choma D, Daures JP, Quantin X, Pujol JL. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer. 2001;85:14\u201322.","journal-title":"Br J Cancer"},{"key":"2172_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000445952","volume":"91","author":"H Otsu","year":"2016","unstructured":"Otsu H, Iimori M, Ando K, Saeki H, Aishima S, Oda Y, Morita M, Matsuo K, Kitao H, Oki E, et al. Gastric Cancer patients with high PLK1 expression and DNA aneuploidy correlate with poor prognosis. Oncology. 2016;91:31\u201340.","journal-title":"Oncology"},{"key":"2172_CR49","doi-asserted-by":"publisher","first-page":"60218","DOI":"10.18632\/oncotarget.11130","volume":"7","author":"J Xu","year":"2016","unstructured":"Xu J, Huang L, Li J. DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases. Oncotarget. 2016;7:60218\u201329.","journal-title":"Oncotarget"},{"key":"2172_CR50","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s10350-007-9013-6","volume":"50","author":"SE Araujo","year":"2007","unstructured":"Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum. 2007;50:1800\u201310.","journal-title":"Dis Colon Rectum"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02172-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:02:30Z","timestamp":1749114150000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02172-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02172-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"10 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Institutional Ethics Committee of the Changshu Hospital Affiliated to Soochow University (Approval No. 2021-58). The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}